These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 35335943)
1. COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments. Hamed AA; Fandy TE; Tkaczuk KL; Verspoor K; Lee BS Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335943 [TBL] [Abstract][Full Text] [Related]
2. Network bioinformatics analysis provides insight into drug repurposing for COVID-19. Li X; Yu J; Zhang Z; Ren J; Peluffo AE; Zhang W; Zhao Y; Wu J; Yan K; Cohen D; Wang W Med Drug Discov; 2021 Jun; 10():100090. PubMed ID: 33817623 [TBL] [Abstract][Full Text] [Related]
3. Drug repurposing against coronavirus disease 2019 (COVID-19): A review. Luo L; Qiu Q; Huang F; Liu K; Lan Y; Li X; Huang Y; Cui L; Luo H J Pharm Anal; 2021 Dec; 11(6):683-690. PubMed ID: 34513115 [TBL] [Abstract][Full Text] [Related]
4. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing. Wu Y; Warner JL; Wang L; Jiang M; Xu J; Chen Q; Nian H; Dai Q; Du X; Yang P; Denny JC; Liu H; Xu H JCO Clin Cancer Inform; 2019 May; 3():1-9. PubMed ID: 31141421 [TBL] [Abstract][Full Text] [Related]
5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
6. Cluster-based text mining for extracting drug candidates for the prevention of COVID-19 from the biomedical literature. Supianto AA; Nurdiansyah R; Weng CW; Zilvan V; Yuwana RS; Arisal A; Pardede HF; Lee MM; Huang CH; Ng KL J Taibah Univ Med Sci; 2023 Aug; 18(4):787-801. PubMed ID: 36618881 [TBL] [Abstract][Full Text] [Related]
7. AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementia. Sikirzhytskaya A; Tyagin I; Sutton SS; Wyatt MD; Safro I; Shtutman M bioRxiv; 2024 Jun; ():. PubMed ID: 38895485 [TBL] [Abstract][Full Text] [Related]
8. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Yin J; Li C; Ye C; Ruan Z; Liang Y; Li Y; Wu J; Luo Z Comput Struct Biotechnol J; 2022; 20():824-837. PubMed ID: 35126885 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 Knowledge Extractor (COKE): A Tool and a Web Portal to Extract Drug - Target Protein Associations from the CORD-19 Corpus of Scientific Publications on COVID-19. Korn D; Pervitsky V; Bobrowski T; Alves VM; Schmitt C; Bizon C; Baker N; Chirkova R; Cherkasov A; Muratov E; Tropsha A ChemRxiv; 2020 Nov; ():. PubMed ID: 33269341 [No Abstract] [Full Text] [Related]
10. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections. Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752 [TBL] [Abstract][Full Text] [Related]
11. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario. Gudadappanavar AM; Benni J J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964 [TBL] [Abstract][Full Text] [Related]
12. TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19. Ansari MA; Jamal QMS; Rehman S; Almatroudi A; Alzohairy MA; Alomary MN; Tripathi T; Alharbi AH; Adil SF; Khan M; Shaheer Malik M Arab J Chem; 2020 Nov; 13(11):8069-8079. PubMed ID: 34909057 [TBL] [Abstract][Full Text] [Related]
13. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures. Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M Front Immunol; 2019; 10():60. PubMed ID: 30761132 [TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
16. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data. Das S; Camphausen K; Shankavaram U Res Sq; 2020 Jun; ():. PubMed ID: 32702730 [TBL] [Abstract][Full Text] [Related]
17. No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19. Rogosnitzky M; Berkowitz E; Jadad AR JMIRx Med; 2020; 1(1):e19583. PubMed ID: 33724265 [TBL] [Abstract][Full Text] [Related]
18. Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer-Aided Drug Repurposing. Oprea TI; Nielsen SK; Ursu O; Yang JJ; Taboureau O; Mathias SL; Kouskoumvekaki L; Sklar LA; Bologa CG Mol Inform; 2011 Mar; 30(2-3):100-111. PubMed ID: 22287994 [TBL] [Abstract][Full Text] [Related]
19. A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. Liu R; Wei L; Zhang P Nat Mach Intell; 2021 Jan; 3(1):68-75. PubMed ID: 35603127 [TBL] [Abstract][Full Text] [Related]